https://www.selleckchem.com/pr....oducts/sp-600125.htm
improvement decreased by 10% (HR=0.90, 95% CI=0.84-0.96). CONCLUSIONS Delayed treatment start in this POMS cohort was associated with shorter time to reach sustained EDSS 4 and confirmed EDSS worsening, and decreased chance of reaching confirmed EDSS improvement, and thus support early treatment start in POMS patients. BACKGROUND Outcome measures typically used to evaluate disease modifying therapies (DMTs) provide important information regarding their effects on disease activity, but they do not capture the full impact of living with
Like
Comment
Share
